Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves Sun Pharma’s tildrakizumab for moderate-to-severe plaque psoriasis

pharmaceutical-technologyMay 27, 2017

Tag: Sun Pharma , plaque psoriasis

PharmaSources Customer Service